Treatment for chronic hepatitis C could potentially be shortened from the standard 12 weeks to eight weeks for treatment-naive patients without cirrhosis, following findings from an Indian Council of Medical Research (ICMR)-funded clinical trial published in The Lancet. The RESOLVE trial, led by researchers from Sanjay

